Journal: American journal of respiratory and critical care medicine
Article Title: Balanced Crystalloids versus Saline in the Intensive Care Unit: The SALT Randomized Trial.
PMID/MRN: 27749094
Publication Date: 2016-Oct-17
Abstract:
Saline is the intravenous fluid most commonly administered to critically ill adults, but may be associated with acute kidney injury and death. Whether use of balanced crystalloids rather than saline affects patient outcomes remains unknown.
To pilot a cluster-randomized, multiple-crossover trial using software tools within the electronic health record to compare saline to balanced crystalloids.
Cluster-randomized, multiple-crossover trial among 974 adults admitted to a tertiary medical intensive care unit from February 3, 2015 through May 31, 2015. The intravenous crystalloid used in the unit alternated monthly between saline (0.9% sodium chloride) and balanced crystalloids (Lactated Ringer's solution or Plasma-Lyte AĻ). Enrollment, fluid delivery, and data collection were performed using software tools within the electronic health record. The primary outcome was the difference between study groups in the proportion of isotonic crystalloid administered that was saline. The secondary outcome was the Major Adverse Kidney Events within 30 days (MAKE30) composite of death, dialysis, or persistent renal dysfunction.
Patients assigned to saline (n=454) and balanced crystalloids (n=520) were similar at baseline and received similar volumes of crystalloid by 30 days (median [IQR]: 1424 [500-3377] mL vs 1617 [500-3628] mL; P = 0.40). Saline comprised a larger proportion of the isotonic crystalloid given in the saline group than in the balanced crystalloid group (91% vs 21%; P < 0.001). MAKE30 did not differ between groups (24.7% vs 24.6%, P = 0.98).
An electronic health record-embedded, cluster-randomized, multiple-crossover trial comparing saline with balanced crystalloids can produce well-balanced study groups and separation in crystalloid receipt. Clinical trial registration available at www.clinicaltrials.gov, ID NCT0234548.